Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Dermoscopy is a useful tool for diagnosing and managing topical steroid dependent face.

Minoxidil solution had low effect, causing 99% to stop using it.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Most dermatologists use and find oral minoxidil effective and tolerable for hair loss treatment.

UV light might cause excessive hair growth by increasing PGE2 in the skin.

Stress-related hair loss was reversed with a special medication.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Minoxidil mixed with 2-hydroxypropyl-β-cyclodextrin in water can improve hair growth more than minoxidil alone.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Ketoconazole cream effectively treats fungal skin infections in cats.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

A rare skin disorder, nevus comedonicus, can appear on one side of the body following Blaschko's lines.

PRP with topical minoxidil is the most effective treatment for increasing hair density in androgenetic alopecia.

Hair care products reduced hair roughness, a combination of Stemoxydine and Resveratrol increased hair density, fermented mackerel oil promoted hair growth, and genes TERT and Bmi-1 helped create new hair follicles.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

The document explains various skin conditions and their treatments.